VPIM
BMGL

Vanguard Personalized Indexing Management’s Basel Medical BMGL Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio BMGL Stock Details BMGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,842
Closed -$40.2K – 2090
2025
Q3 		$40.2K Buy
+1,842
New +$46.2K ﹤0.01% 1924

Other funds holding BMGL

GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BIA
Bell Investment Advisors Oakland, California $639M AUM 13.28% 1-Year Est. Return

Vanguard Personalized Indexing Management's BMGL Position: Q4 2025 in Review

Vanguard Personalized Indexing Management sold out of Basel Medical (BMGL) in Q4 2025, closing a stake of 1,842 shares — an estimated $40.2K sold.

Vanguard Personalized Indexing Management first reported a position in BMGL in Q3 2025 and held it in 1 quarter. The position peaked at $40.2K in Q3 2025. 9 funds tracked by Wall St. Rank hold BMGL as of Q4 2025.

  • Vanguard Personalized Indexing Management reported no remaining Basel Medical position as of Q4 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 1,842 Basel Medical shares in Q4 2025, an estimated $40.2K.
  • Vanguard Personalized Indexing Management first reported a position in Basel Medical in Q3 2025 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Basel Medical position peaked at $40.2K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held Basel Medical as of Q4 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2025, filed 13 Feb 2026.